Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Danirixin in Healthy Elderly
NCT03457727Phase 1Completed
- Sponsor
- GSK
- Start
- Mar 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of danirixin in chronic obstructive pulmonary disease (COPD) (2 cohorts), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time 0 to Infinity, Maximum Observed Concentration and 4 more. Started Mar 2018; status: completed.
02
Drugs
danirixin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03457727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03457727.